Skip to main content
Premium Trial:

Request an Annual Quote

Abbott to Distribute More Diagnostic Tests from Artus

NEW YORK, April 15 (GenomeWeb News) - Abbott Laboratories will distribute additional molecular diagnostic tests from Artus, the companies said yesterday.


Under the expanded agreement, Abbott will offer all real-time-PCR-based diagnostic tests developed by Artus of Hamburg, Germany, that run on Applied Biosystems instruments. These include tests for hepatitis B virus, Epstein Barr virus, Varicella Zoster virus, Parvo B19 virus, cytomegalovirus, herpes simplex virus, and enterovirus.


Abbott already distributes Artus' tests for SARS, Chlamydia trachomatis, and Mycobacterium tuberculosis, as well as other assays on the ABI platform. Abbott markets these test through an exclusive alliance with Celera Diagnostics.

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.